We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · August 10, 2020

Addition of Primary Metastatic Site in Bone, Brain, and Liver to IMDC Criteria in Patients With mRCC

Clinical Genitourinary Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Genitourinary Cancer
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study
Clin Genitourin Cancer 2020 Jun 27;[EPub Ahead of Print], F Massari, V Di Nunno, A Guida, CA Costa Silva, L Derosa, V Mollica, E Colomba, G Brandi, L Albiges

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading